Cardiovascular risk assessment and prevention for high-risk adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial evaluates a risk-based dynamic monitoring strategy aimed at preventing cardiovascular diseases in high-risk adults aged 40 to 79 in Yinzhou District, China. It involves a cluster randomized design where 216 clinics will either implement the intervention, which includes regular cardiovascular risk assessments and monitoring supported by a web-based system, or continue with usual care. The study will assess changes in cardiovascular risk scores over 24 months and track major adverse cardiovascular events over 60 months. The goal is to determine the effectiveness of this comprehensive strategy in reducing cardiovascular risks and events.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Residents in the Yinzhou District have a unique health ID;
* Aged 40 to 79 years at the baseline enrollment;
* With high risk of cardiovascular disease evaluated by the 2019 WHO laboratory-based risk models (10-year risk≥10%);

Exclusion Criteria:

* Have a history of coronary heart disease, stroke or heart failure;
* Patients with a diagnosis of cancer;
* Refused to provide written informed consent

Where it's running

• Yinzhou District Center for Disease Control and Prevention
  Ningbo, Zhejiang, China Recruiting

Study contacts

• Principal investigator: Xun TANG, PhD, MHS
• Study coordinator: Xun TANG, PhD, MHS
• Email: tangxun@bjmu.edu.cn
• Phone: +86-10-82801528 ext 317

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.